Pharmacokinetics and bioavailability of α-, γ- and δ-tocotrienols under different food status
- 1 January 2001
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 53 (1) , 67-71
- https://doi.org/10.1211/0022357011775208
Abstract
We have investigated the pharmacokinetics and bioavailability of α-, γ- and δ-tocotrienols under fed and fasted conditions in eight healthy volunteers. The volunteers were administered a single oral dose of mixed tocotrienols (300 mg) under fed or fasted conditions. The bioavailability of tocotrienols under the two conditions was compared using the parameters peak plasma concentration (Cmax), time to reach peak plasma concentration (Tmax) and total area under the plasma concentration-time curve (AUC0-∞). A statistically significant difference was observed between the fed and fasted logarithmic transformed values of Cmax (P < 0.01) and AUC0-∞ (P < 0.01) for all three tocotrienols. In addition, the 90% confidence intervals for the ratio of the logarithmic transformed AUC0-∞ values of α-, γ- and δ-tocotrienols under the fed state over those of the fasted state were found to lie between 2.24-3.40, 2.05-4.09 and 1.59-3.81, respectively, while those of the Cmax were between 2.28-4.39, 2.31-5.87 and 1.52-4.05, respectively. However, no statistically significant difference was observed between the fed and fasted Tmax values of the three homologues. The mean apparent elimination half-life (t1/2) of α-, γ- and δ-tocotrienols was estimated to be 4.4, 4.3 and 2.3 h, respectively, being between 4.5- to 8.7-fold shorter than that reported for α-tocopherol. No statistically significant difference was observed between the fed and fasted t1/2 values. The mean apparent volume of distribution (Vd/f) values under the fed state were significantly smaller than those of the fasted state, which could be attributed to increased absorption of the tocotrienols in the fed state.Keywords
This publication has 11 references indexed in Scilit:
- Improved bioavailability of vitamin E with a self emulsifying formulationInternational Journal of Pharmaceutics, 2000
- Simple high-performance liquid chromatographic method for the determination of tocotrienols in human plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1999
- Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor statusLipids, 1998
- Response of hypercholesterolemic subjects to administration of tocotrienolsLipids, 1995
- Inhibition of tumour promotion by various palm‐oil tocotrienolsInternational Journal of Cancer, 1994
- Differences in the Plasma Transport and Tissue Concentrations of Tocopherols and Tocotrienols: Observations in Humans and HamstersExperimental Biology and Medicine, 1993
- Palm oil vitamin E protects against ischemia/reperfusion injury in the isolated perfused langendorff heartNutrition Research, 1992
- Dietary tocotrienols reduce concentrations of plasma cholesterol, apolipoprotein B, thromboxane B2, and platelet factor 4 in pigs with inherited hyperlipemiasThe American Journal of Clinical Nutrition, 1991
- Kinetics of D-α-tocopherol in a water soluble base in manJournal of Pharmacy and Pharmacology, 1985
- PharmacokineticsPublished by Taylor & Francis ,1982